Article
Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.
Genes - 4 Oct 2023
Meira Débora Dummer, de Castro E Caetano Maria Clara, Casotti Matheus Correia, Zetum Aléxia Stefani Siqueira, Gonçalves André Felipe Monteiro, Moreira André Rodrigues, de Oliveira Augusto Henrique, Pesente Fellipe, Santana Gabriel Mendonça, de Almeida Duque Daniel, Pereira Gierleson Santos Cangussu, de Castro Giulia de Souza Cupertino, Pavan Isabele Pagani, Chagas João Pedro Sarcinelli, Bourguignon José Henrique Borges, de Oliveira Juliana Ribeiro, Barbosa Karen Ruth Michio, Altoé Lorena Souza Castro, Louro Luana Santos, Merigueti Luiza Poppe, Alves Lyvia Neves Rebello, Machado Marlon Ramos Rosado, Roque Maria Luísa Rodrigues Oliveira, Prates Pedro Santana, de Paula Segáua Sayuri Honorio, Dos Santos Uchiya Taissa, Louro Thomas Erik Santos, Daleprane Vinicius Eduardo, Guaitolini Yasmin Moreto, Vicente Creuza Rachel, Dos Reis Trabach Raquel Silva, de Araújo Bruno Cancian, Dos Santos Eldamária de Vargas Wolfgramm, de Paula Flávia, Lopes Tiago José S, de Carvalho Elizeu Fagundes, Louro Iúri Drumond
Abstract excerpt
Lung cancer is a highly aggressive neoplasm and, despite the development of recent therapies, tumor progression and recurrence following the initial response remains unsolved. Several questions remain unanswered about non-small cell lung cancer (NSCLC): (1) Which patients will actually benefit from therapy? (2) What are the predictive factors of response to MAbs and TKIs? (3) What are the best combination...
Topics
Join the communities discussing this publication.